Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

52 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-31

Study Completion Date

2025-04-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Surveillance for Leishmaniasis Skin Lesions in Mali

NCT00344084

Cutaneous Leishmaniasis

COMPLETED

Short Course Regimens for Treatment of PKDL (Sudan)

NCT03399955

PKDL - Post-Kala-Azar Dermal Leishmanioid

UNKNOWN PHASE2

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

NCT01980199

Visceral Leishmaniasis

TERMINATED PHASE2

Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease

NCT06692985

Cutaneous Leishmaniasis

COMPLETED

Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure

NCT05426577

Visceral Leishmaniasis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective, observational cohort study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis from a hospital in Lankien, South Sudan.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leishmaniasis Leishmaniasis, Visceral Post-kala-azar Dermal Leishmaniasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary visceral leishmaniasis patients who had a confirmed (serological and/or parasitological) diagnosis at admission, and who were discharged after successful treatment
* Availability for follow up visits
* Provision of informed consent, and in the case of minors 12 to 17 years of age, assent as well

Exclusion Criteria

* Unavailability for follow-up visits due to distance, inaccessibility, or refusal to participate
* Diagnosis of prior primary visceral leishmaniasis done only on clinical basis

Eligible Sex

ALL

Accepts Healthy Volunteers

No